Chemokines, chemokine receptors and CNS pathology-background
Chemokines are small proin¯ammatory cytokines which stimulate migration of in¯ammatory cells in vitro and in vivo. They can be divided according to structure, function and gene localization into four different subfamilies. Chemokines have been ascribed diverse additional functions, including regulation of angiogenesis, control of cell proliferation and developmental tissue patterning.
The suspicion that chemokines could be involved in CNS pathology emerged from considering their target-cell speci®city, in light of the selective recruitment of leukocyte populations to the intrathecal compartment in diverse disease processes. Initial studies of chemokine expression in the CNS were performed in models including experimental autoimmune encephalomyelitis (EAE), stroke and meningitis. Early results from these investigations provided the exciting insight that parenchymal CNS cells were among the most abundant sources of chemokines, both in vitro and in vivo. A landmark observation from Karpus et al (1995) was that EAE could be abrogated by passive immunization with antibodies to a single chemokine, MIP-1a.
Chemokine receptors have also found a place in the unique pathologies of the nervous system. Evident relationships between chemokines that function in speci®c processes and response by appropriate hematogenous receptor-bearing cells have been demonstrated. Of more novelty (if less well understood) has been the ®nding that chemokine receptors such as CXCR4, CXCR2, CX3CR1 and the Duffy antigen receptor for chemokines (DARC) are expressed by resident neuroepithelial cells. These varied observations point to a fascinating, diverse and complex array of biological roles for these products in the CNS. Preliminary results in this ®eld are reviewed in this manuscript and summarized in the Tables.
Chemokines in experimental autoimmune encephalomyelitis (EAE)
EAE is a model of organ-speci®c autoimmunity, and is a useful experimental system for examining certain aspects of the human disorder multiple sclerosis (MS). The disorder is induced in susceptible animals (mice, rats, guinea pigs or nonhuman primates) with injections of myelin antigens in emulsion. The most common practice at present is to immunize with either whole spinal cord homogenate, myelin protein preparations or peptides derived from myelin proteins. The cardinal encephalitogenic proteins of myelin are myelin basic protein (MBP), myelin proteolipid protein (PLP) and myelin oligodendroglial glycoprotein (MOG).
It has been shown that chemokine upregulation occurs in EAE and correlates with disease appearance (Hulkower et al, 1993; Ransohoff et al, 1993; Godiska et al, 1995; Glabinski et al, 1996a) . Godiska and coworkers observed increased expression of mRNA for several chemokines including RANTES, MIP-1a, MIP-1b, TCA3, IP-10 MCP-1 KC, and MCP-3 in spinal cord before clinical signs appeared. They reported also that encephalitogenic T cells expressed transcripts for RANTES, MIP-1a, MIP-1b and TCA3 (Godiska et al, 1995) . We observed very transient expression of MCP-1 and IP10 at the beginning of acute EAE (Ransohoff et al, 1993) .
Analysis of chemokine gene expression and histological ®ndings suggested that chemokines amplify but not initiate invasion of CNS by in¯ammatory cells from the blood (Glabinski et al, 1996a) . In situ hybridization showed that several chemokines are expressed by astrocytes in near vicinity of in¯am-matory cuffs (Ransohoff et al, 1993; Glabinski et al, 1996a; Tani et al, 1996b) .
In chronic-relapsing EAE we observed increased expression at the mRNA and protein level of ®ve chemokines (MCP-1, IP-10, MIP-1alpha, GROalpha, RANTES) during spontaneous relapse of the disease (Glabinski et al, 1997) . Three of them were expressed by astrocytes (MCP-1, IP-10 and GRO-alpha), two others (MIP-1 alpha and RANTES) by in¯ammatory cells (Glabinski et al, 1997) .
As noted above, Karpus and colleagues provided support for the functional importance of chemokine expression in EAE by passive immunization studies. Anti-MIP-1a blocked initial attacks of EAE after adoptive transfer of activated antigen-speci®c T-cells blasts (Karpus et al, 1995) . Interestingly, anti-MCP-1 antibodies, which were inert towards initial attacks, signi®cantly reduced relapses of disease, which were unaffected by anti-MIP-1a (Karpus et al, 1997) . These results indicated complex and nonredundant functions of individual b-chemokines in EAE (Karpus et al, 1998) .
Chemokines in nonimmunologic CNS injury
Shortly after mechanical trauma to the CNS in¯ammatory cells migrate from the blood to the injury site and begin the process of tissue repair. The cellular signals for that migration are not known. The functions of chemokines suggest that they are attractive candidates for that role. We analzyed four models of CNS trauma: nitrocellulose membrane stab or implant injury to the adult or neonatal cortex. In the models of mechanical injury to the adult brain we observed increased expression of the mRNA for MCP-1 3 h after injury . MCP-1 protein was detected at 12 h postinjury. In the neonatal stab injury model characterized by lack of in¯ammation MCP-1 expression was signi®cantly lower than in other models. Other analyzed chemokines (IP-10, MIP-1a, GRO-a) were not detected at the mRNA or protein level. In situ hybridization experiments combined with immunocytochemistry showed that astrocytes in the vicinity of the injury site were the cellular source of MCP-1 . Similar kinetics of MCP-1 expression was described in rat models of mechanical injury (Berman et al, 1996) . It has been shown also in rat stab wound brain injury that reactive astroyctes may express MIP-1b following trauma (Ghirnikar et al, 1996) . After cryogenic lesion to the cerebral cortex MCP-1 mRNA expression peaked at 6 h, remained elevated for 24 h and then declined by 48 h. IP-10 expression was not upregulated in that brain injury model (Grzybicki et al, 1998) . Compatible results were reported by Hausmann and colleagues, who found selective upregulation of MCP-1 expression after sterile but not LPS-augmented cerebral trauma (Hausmann et al, 1998) .
There are several reports showing increased expression of some chemokines in experimental models of brain ischemia. This may suggest that locally produced chemokines may stimulate inammatory cell migration to the ischemic area and contribute to brain injury in ischemic stroke. Kim and coworkers observed increased expression of mRNA for two chemokines (MCP-1 and MIP-1a) 6 h after induction of cerebral ischemia, with peak expression at 24 ± 48 h (Kim et al, 1995) . Immunostaining suggested that MCP-1 positive cells were endothelial cells and macrophages in the ischemic area. The morphology of MIP-1a positive cells was similar to GFAP-positive astrocytes (Kim et al, 1995) . Contradictory results were published by others who showed by double in situ hybridization that MIP-1a is produced by Mac-1 positive microglial cells with peak of expression 4 ± 6 h after onset of occlusion (Takami et al, 1997) . Increased MCP-1 mRNA expression at 6 h after occlusion of middle cerebral artery (MCAO) has also been reported. The kinetics of MCP-1 expression was similar after permanent MCAO or MCAO reperfusion (Wang et al, 1995) .
Astrocytes were the cellular source of MCP-1 from 6 h to 2 days after MCAO, as reported by Gourmala et al (1997) . At later time points MCP-1 was detected in macrophages and reactive microglia in the ischemic area (Gourmala et al, 1997) . Increased MCP-1 expression has been observed as early as 1 h after reperfusion in the rat forebrain reperfusion model (Yoshimoto et al, 1997) . Chemokine CINC (cytokine-induced neutrophil chemoattractant) which belongs to IL-8 family and is a potent neutrophil chemoattractant in rats, was overexpressed in the cerebral cortex of rats 6 ± 12 h after MCAO (Liu et al, 1993) . Another group observed increased CINC expression in the brain and serum 3 ± 12 h after reperfusion. One hour of ischemia without reperfusion did not produce increase in CINC expression in the brain (Yamasaki et al, 1995) .
Expression of chemokines in the CNS of transgenic mice
Most of the early information about chemokines and their physiological roles came from in vitro studies. Those results could not be directly extrapolated to the in vivo situation. This problem has been addressed by the demonstration that pro-grammed expression of chemokine genes in the CNS can trigger the recruitment of leukocytes in vivo (Lira et al, 1997) . MCP-1 transgene expressed in oligodendrocytes under control of MBP promoter was able to induce accumulation of in¯ammatory cells within the CNS (Fuentes et al, 1995) . Immunohistochemical staining showed that in®l-trating cells were monocytes/macrophages and they were localized mainly in perivascular areas with minimal parenchymal in®ltration. MCP-1 immunoreactivity was detected at the abluminal surface of cerebral microvessels. The mononuclear cell accumulation was massively ampli®ed at that model by intraparenchymal injection of lipopolysaccharide (LPS). Despite monocyte accumulation no neurological or behavioral signs were observed (Fuentes et al, 1995) .
CNS-speci®c expression of a-chemokine KC, which is a potent neutrophil chemoattractant in vitro produced impressive neutrophil in®ltration into perivascular, meningeal and parenchymal CNS sites . KC expression was detected in oligodendrocytes and colocalized with in®ltrat-ing neutrophils. Three weeks old mice were healthy and behaviorally normal despite remarkable neutrophil accumulation. Beginning at 40 days of age MBP-KC mice developed a neurological syndrome of pronounced postural instability and rigidity. The major neuropathological ®ndings at that time were microglial activation and blood-brain barrier disruption . Results obtained from these experiments suggested that chemokines are potent inducers of in¯ammatory cell migration into the CNS in vivo. Moreover, their activities were target cell-speci®c in vivo and restricted mainly to triggering migration but not activation .
Chemokines in human CNS pathology
Migration of in¯ammatory cells from the blood to the CNS compartment is the principal pathological feature of bacterial meningitis. Most information about chemokine involvement in human CNS pathology comes from studies analyzing chemokine levels in the CSF of patients with meningitis. Spanaus and collaborators analyzed by ELISA concentrations of several chemokines in the CSF of patients with pyogenic meningitis (Spanaus et al, 1997) . They found signi®cantly increased levels of IL-8, GRO-a, MIP-1a, and MIP-1b but not RANTES, when compared with nonin¯ammatory CSF controls. The CSF from meningitis patients was chemotactic in vitro for neutrophils and mononuclear leukocytes and the migration was diminished by speci®c anti-chemokine antibodies (Spanaus et al, 1997) . In another study elevated levels of IL-8, GRO-a and MCP-1 were found in the CSF from patients with bacterial and aseptic meningitis but not in parallel blood serum specimens (Sprenger et al, 1996) . Number of granulocytes in the CSF from bacterial meningitis patients correlated with IL-8 and GRO-a levels, whereas MCP-1 level correlated well with mononuclear cell count in aseptic meningitis (Sprenger et al, 1996) . In another study IL-8 concentration in the CSF was higher than 2.5 ng/ml in all samples from patients with pyogenic meningitis, but also in some samples from patients with nonbacterial meningitis (LopezCortes et al, 1995) . In patients with nonpyogenic meningitis a signi®cant correlation between IL-8 levels and CSF granulocyte counts was found (Lopez-Cortes et al, 1995) . These results suggest that chemokines are involved in in¯ammatory cell accumulation in the subarachnoid space.
MIP-1a in the CSF was reported to be increased in multiple sclerosis patients during relapse as well as in CSF from patients with Behcet's disease and HTLV-1 associated myelopathy. MIP-1a level in that study correlated with leukocyte and protein concentration in the CSF (Miyagishi et al, 1995) . Increased level of IL-8 was also detected in CSF of patients with severe brain trauma, at higher levels in CSF than in corresponding serum and correlated directly with blood-brain barrier dysfunction (Kossmann et al, 1997).
There is little information about cellular sources of chemokine production during human CNS pathology. MCP-1 immunoreactivity was detected in reactive microglia and mature but not in immature senile plaques in autopsy specimens from ®ve Alzheimer disease patients (Ishizuka et al, 1997) . Simpson and coworkers demonstrated expression of MCP-1 protein by astrocytes bordering active MS lesions, compatible with prior observations in EAE, trauma and cerebral ischemia models (Simpson et al, 1998) . Hvas et al showed that RANTES mRNA was expressed by perivascular in¯ammatory cells in MS brain sections as previously reported in EAE (Hvas et al, 1997) .
Chemokine expression by CNS cells in vitro
MCP-1 was originally puri®ed in 1989 from the culture supernatant of a glioma cell line (Yoshimura et al, 1989) . Since that time numerous studies on chemokine expression by CNS cells in vitro have been published. Many human glioma cell lines were shown to produce IL-8 and MCP-1, while none of neuroblastoma cell lines expressed these cytokines (Morita et al, 1993) . In other studies IL-8 was produced by ®ve astrocytoma cell lines (Nitta et al, 1992) and also in some glioblastoma cell lines (Kasahara et al, 1991) . Cultured astroyctes stimulated by cytokines TNFa and TGFb express MCP-1 mRNA and protein (Hurwitz et al, 1995) . IFNg can also stimulate MCP-1 expression by astrocytoma cell line (Zhou et al, 1998) . Additionally, stimulated astrocytes can express MIP-1a and MIP-1b and RANTES (Barnes et al, 1996) . LPS, IL-1b and TNF-a stimulate production of MCP-1 by astrocytes but not microglia (Hayashi et al, 1995) . HIV-1 transactivator protein Tat signi®cantly increase astrocyte production of MCP-1, but not RANTES, MIP-1a and MIP-1b suggesting that HIV may induce monocyte in®ltration in the CNS via astrocyte stimulation (Conant et al, 1998) . IP-10 and RANTES expression can be upregulated in primary rat astrocytes and microglia by the infection of neurotropic paramyxovirus NDV (Fisher et al, 1995) . Beta amyloid peptide is able to stimulate expression of IL-8 by human astrocytoma cells (Gitter et al, 1995) .
Microglial cells are critical for CNS response to varied forms of injury. When stimulated in vitro by LPS, IL-1b and TNFa they can produce IL-8. Pretreatment with IL-4, IL-10 or TGF-beta 1 inhibited the stimulatory effects of these proin¯am-matory cytokines (Ehrlich et al, 1998) . Cryptococcal polysaccharide was also capable of inducing IL-8 production by human fetal microglial cells showing that some fungi can stimulate endogenous CNS cells to express chemokines (Lipovsky et al, 1998) .
Human cultured microglia produce MIP-1a, MIP1b and MCP-1 in response to LPS, TNFa or IL-1b (McManus et al, 1998) . Moreover MCP-1 expression by brain macrophages can be also stimulated by IL-6 and CSF-1 (Calvo et al, 1996) as well as the active fragment of beta amyloid (Meda et al, 1996) . This last observation gives new insight into mechanisms underlying amyloid plaque formation in the CNS during Alzheimer disease. Microglial cells infected by SIV in vitro can produce more IL-8 than uninfected cultures (Sopper et al, 1996) .
TNFa treatment of mixed human brain cell cultures stimulated higher expression of RANTES and MIP-1b than observed after similar stimulation of microglial cells (Lokensgard et al, 1997) . Cultured brain endothelial cells were shown to express mRNA for MCP-1. Treatment with TNFa increased MCP-1 expression in a dose-dependent manner (Zach et al, 1997) . Bovine brain microvessel endothelial cells showed increased expression of IL-8 after infection with bacterial parasite C. ruminantium (Bourdoulous et al, 1995) .
Chemokine receptors ± overview
Chemokines act on target cells via seven-transmembrane-domain receptors that signal through GTPbinding proteins. Two main subgroups of chemokine receptors have been described: CXC chemokine receptors (CXCR) with 36 ± 77% and CC chemokine receptors (CCR) with 46 ± 89% identical amino acids (Baggiolini et al, 1997) . Lately a receptor for CX 3 C chemokine-fractalkine/neurotactin was identi®ed (Imai et al, 1997) , so far there is no known receptor for C chemokine lymphotactin. The largest family of chemokine receptors are CCR receptors consisted of ten receptor types in human (CCR1 ± CCR10). CXCR receptor family includes four types of receptors in humans (CXCR1 ± CXCR5). Chemokine receptors can be categorized into four different subgroups: shared, speci®c, promiscuous and viral (Premack and Schall, 1996) . Most of the chemokine receptors can bind more than one chemokine ligand belonging to the same chemokine subfamily (shared group). CXCR2 binds several CXC chemokines that contain a canonical glutamate-leucine-arginine (ELR) motif. CXCR3 binds non-ELR CXC chemokines including b-R1/I-TAC (Cole et al, 1998; Rani et al, 1996) , IP-10 and Mig. All CCR receptors have several ligands. There is a promiscuous chemokine receptor designated as DARC which is identical to Duffy blood group antigen on erythrocytes. It binds chemokines from CC and CXC subfamilies and it is postulated that it works in the blood as a`sink' for chemokines because of the lack of signaling. Two (among several other) viruses encode chemokine receptors: Cytomegalovirus (CMV US28) and Herpes virus saimiri (HSV ECRF3) (Murphy, 1996; Premack and Schall, 1996) . The role of virally encoded chemokine receptors is unknown but preservation of signaling function is of considerable interest (Murphy, 1996) .
Chemokine receptors in CNS pathology
Expression of several different chemokine receptors has been detected in the normal CNS as well as in cultured cells derived from CNS components (Tables 1 and 2 ). The fractalkine receptor CX3CR1 was detected at surprisingly high levels in normal brain and spinal cord in both human and rodent specimens before its response to the fractalkine ligand was described (Combadiere et al, 1995; Harrison et al, 1994; Imai et al, 1997) . Fractalkine was also demonstrated to be highly abundant in normal CNS tissues and upregulated in pathology, suggesting important functions for this ligandreceptor system in neural physilogy (Bazan et al, 1997; Pan et al, 1997) . Horuk and coworkers detected the DARC receptor on cerebellar Purkinje cells in archival human brain sections (Horuk et al, 1996) and CXCR-2 on projection nuerons in diverse regions of the brain and spinal cord . The same group reported detection of chemokine receptors CCR1, CCR5, CXCR2 and CXCR4 by immunohistochemistry in cultured human neurons . Transcripts for CXCR4 were identi®ed also by Northern blot (Heesen et al, 1996a; Nagasawa et al, 1996) and RT ± PCR in cultured primary mouse astrocytes. Cultured astrocytes were shown to express also CCR1 (Tanabe et al, 1997 ), but not CCR2 and CXCR2 (Heesen et al, 1996b) . Other studies con®rmed that CXCR4 is expressed by microglia in human and mouse brain (He et al, 1996) . The single unequivocal demonstration that chemokine receptors are important for developmental neural patterning comes from the ®nding that CXCR4 knockout mice exhibit abnormal formation of the CNS (Littman, 1998) . Two alternatively spliced forms of mouse CXCR4 have been identi®ed both of which are expressed by cultured astrocytes and microglia . Several orphan chemokine receptor-like proteins were detected in the CNS. They have structure similar to chemokine receptors but their ligands Ransohoff et al, 1993; Godiska et al, 1995; Glabinski et al, 1996; Karpus et al, 1995; Tani et al, 1996; Pan et al, 1997; Glabinski et al, 1997; Berman et al, 1996; Miyagishi et al, 1995 MCP-1, MIP-1a, MIP-1b Mechanical injury Mouse, Rat
Astrocytes, macrophages, endothelial cells, microglia Glabinski et al, 1996; Berman et al, 1996; Ghirnikar et al, 1996; Hausmann et al, 1998; McTigue et al, 1998 Wang et al, 1995; Lu et al, 1993; Yamasaki et al, 1995; Kim et al, 1995; Takami et al, 1997; Gourmaia et al, 1997; Ivacko et al, 1997 have not been identi®ed so far. One of them is CXCR5 receptor isolated initially from Burkitt's lymphoma cells but expressed also in mature B cells and in brain neurons (Kaiser et al, 1993) .
Another example of orphan chemokine-like receptors in a family of LCR-1 receptors identi®ed initially in bovine locus coeruleus, later rat and sheep homologs were found (Wong et al, 1996) . Ehrlich et al, 1998; Lipovsky et al, 1998; Lokensgard et al, 1997; Sopper et al, 1996; Sun et al, 1997; Hurwitz et al, 1995; Fisher et al, 1995; Hayashi et al, 1995; Meda et al, 1996; Calvo et al, 1996 MCP-1, IL-8 Stimulated cerebral endothelium Human, bovine, porcine, murine 
